Skip to main content
. 2005 Jun;73(6):3677–3685. doi: 10.1128/IAI.73.6.3677-3685.2005

FIG. 1.

FIG. 1.

Local reactogenicity in recipients of the AMA1-C1 vaccine. The percentages of volunteers who experienced injection site erythema (A), induration (B), or tenderness (C) after the first (black bar), second (gray bar), and third (white bar) immunizations with 5 μg, 20 μg, or 80 μg of AMA1-C1 are presented.